Centre for Translational Medicine, Semmelweis University, Budapest, Hungary.
Division of Pancreatic Diseases, Semmelweis University, Budapest, Hungary.
J Ovarian Res. 2024 May 17;17(1):104. doi: 10.1186/s13048-024-01423-2.
The incidence of infertility caused by diminished ovarian reserve has become a significant problem worldwide. The beneficial effect of PRP treatment of the ovaries has already been described, but the high-level evidence of its effectiveness has not yet been proven.
A systematic search was performed in five databases, until March 12th, 2024. Both randomized and non-randomized studies that compared PRP treatment of the ovaries to self-control among women with diminished ovarian reserve were eligible for inclusion. Hormonal levels (Anti-Müllerian hormone (AMH), Follicle stimulating hormone (FSH), Luteinizing hormone (LH), Estradiol (E2), In-vitro fertilization parameters (Antral follicle count, oocyte, and embryo count), biochemical and spontaneous pregnancy and livebirth were measured.
38 eligible studies were identified reporting on 2256 women. The level of AMH rised, the level of FSH decreased significantly after the PRP treatment. AMH 1 month MD 0.20 (n = 856, p > 0.001, 95% CI: [0.12;0.28]), 2 months MD 0.26 (n = 910, p = 0.013, 95% CI: [0.07;0.44]), 3 months MD 0.36 (n = 881, p = 0.002,95% CI: [0.20;0.52]). FSH 1 month MD -10.20 (n = 796, p > 0.039, 95% CI: [-19.80;-0.61]), 2 months MD -7.02 (n = 910, p = 0.017, 95% CI: [-12.48; -1.57]), 3 months MD -8.87 (n = 809, p = 0.010, 95% CI: [-14.19; -3.55]). The antral follicle count elevated significantly MD 1.60 (n = 1418, p = < 0.001, 95% CI: [0.92; 2.27]). Significant improvement was observed in the number of retrieved oocytes MD 0.81 (n = 802, p = 0.002, 95% CI: [0.36; 1.26]), and embryos created MD 0.91 (n = 616, p = 0.001, 95% CI: [0.45;1.36]). The incidence of spontaneous pregnancy following PRP treatment showed a rate with a proportion of 0.07 (n = 1370, 95% CI: 0.04-0.12), the rate of biochemical pregnancy was 0.18 (n = 1800, 95% CI: 0.15-0.22), livebirth was 0.11 (n = 1482, 95% CI: 0.07-0.15).
Our meta-analysis showed that based on protocolized analysis of the widest scientific literature search to date, containing predominantly observational studies, PRP treatment resulted in a statistically significant improvement in the main fertility parameters of diminished ovarian reserve women. Further multicenter, randomized trials, with large patient numbers and a longer follow-up period are needed to certify our results and develop the most effective treatment protocol.
卵巢储备功能减退导致的不孕发生率已成为全球重大问题。PRP 治疗卵巢的有益效果已被描述,但尚未证明其有效性的高级别证据。
在五个数据库中进行了系统检索,截至 2024 年 3 月 12 日。符合纳入标准的研究为比较卵巢储备功能减退女性 PRP 治疗与自身对照的随机和非随机研究。测量的激素水平(抗苗勒管激素(AMH)、卵泡刺激素(FSH)、促黄体生成素(LH)、雌二醇(E2)、体外受精参数(窦卵泡计数、卵子和胚胎计数)、生化和自然妊娠及活产。
确定了 38 项符合条件的研究,共报告了 2256 名女性。PRP 治疗后 AMH 水平升高,FSH 水平显著降低。PRP 治疗 1 个月后 AMH MD 0.20(n=856,p>0.001,95%CI:[0.12;0.28]),2 个月后 MD 0.26(n=910,p=0.013,95%CI:[0.07;0.44]),3 个月后 MD 0.36(n=881,p=0.002,95%CI:[0.20;0.52])。FSH 治疗 1 个月后 MD-10.20(n=796,p>0.039,95%CI:[-19.80;-0.61]),2 个月后 MD-7.02(n=910,p=0.017,95%CI:[-12.48;-1.57]),3 个月后 MD-8.87(n=809,p=0.010,95%CI:[-14.19;-3.55])。窦卵泡计数显著升高 MD 1.60(n=1418,p= <0.001,95%CI:[0.92;2.27])。获得的卵子数量明显增加 MD 0.81(n=802,p=0.002,95%CI:[0.36;1.26]),胚胎数量增加 MD 0.91(n=616,p=0.001,95%CI:[0.45;1.36])。PRP 治疗后的自然妊娠发生率为 0.07(n=1370,95%CI:0.04-0.12),生化妊娠发生率为 0.18(n=1800,95%CI:0.15-0.22),活产率为 0.11(n=1482,95%CI:0.07-0.15)。
我们的荟萃分析表明,基于迄今为止最广泛的科学文献检索的方案分析,主要包含观察性研究,PRP 治疗可显著改善卵巢储备功能减退女性的主要生育参数。需要进行更多的多中心、随机试验,纳入大量患者并进行更长时间的随访,以验证我们的结果并制定最有效的治疗方案。